Top Analyst Upgrades & Downgrades: AMD, Amazon, Autodesk, Charles Schwab, Intel, Micron, Regions Financial, Stitch Fix, Uber and More

Print Email

Stocks were indicated to open slightly higher on the prospects of better earnings on Monday, even with oil up as tensions with Iran rise. Despite some profit-taking and some of the market’s key stocks off after earnings, the major indexes remain close to all-time highs. Investors have many reasons to remain cautious, but they also should be considering how they want their assets positioned for the rest of 2019 and beyond.

24/7 Wall St. reviews dozens of analyst research reports each day of the week to find new ideas for investors and traders alike. Some of these analyst reports cover stocks to buy, while others cover stocks to sell or to avoid.

Additional commentary has been added on most of the daily analyst reports, along with trading history. The consensus analyst price targets and other valuation metrics are from the Refinitiv (Thomson Reuters) sell-side research service.

These were the top analyst upgrades, downgrades and initiations seen on Monday, July 22, 2019.

Advanced Micro Devices Inc. (NASDAQ: AMD) was started as Neutral and assigned a $28 target price at Atlantic Equities. Shares closed down 1.5% at $32.51, in a 52-week range of $15.72 to $34.86. The consensus target price is $31.56.

Amazon.com Inc. (NASDAQ: AMZN) was reiterated as Overweight and the target price was raised to $2,200 from $2,100 at KeyBanc Capital Markets. Shares closed down 0.7% at $1,964.52, in a 52-week range of $1,307.00 to $2,050.50. The consensus target price is $2,243.50.

Applied Materials Inc. (NASDAQ: AMAT) was raised to Buy from Neutral and the price target was raised to $56 from $48 at Goldman Sachs. Shares closed down 0.8% at $47.81, in a 52-week range of $28.79 to $50.39. The consensus target price is $51.10.

Autodesk Inc. (NASDAQ: ADSK) was started with a Buy rating and a $210 target price at Citigroup.

BridgeBio Pharma Inc. (NASDAQ: BBIO) was started as Outperform with a $49 target price at BMO Capital Markets.

Brunswick Corp. (NYSE: BC) was maintained as Overweight but the target price was cut to $55 from $65 at KeyBanc Capital Markets.

Charles Schwab Corp. (NYSE: SCHW) was raised to Outperform from Market Perform at Wells Fargo.

Eidos Therapeutics Inc. (NASDAQ: EIDX) was started as Overweight and the price target was set at $55 at Piper Jaffray.

Intel Corp. (NASDAQ: INTC) was started with an Underweight rating and assigned a $38 price target at Atlantic Equities. Shares closed up 0.7% at $50.27, in a 52-week range of $42.36 to $59.59. The consensus target price is $51.74.

Intercontinental Exchange Inc. (NYSE: ICE) was downgraded to Neutral from Buy and the price target was raised to $99 from $92 at Citigroup.

Keysight Technologies Inc. (NYSE: KEYS) was downgraded to Neutral from Buy at Goldman Sachs.

KLA-Tencor Corp. (NASDAQ: KLAC) was raised to Neutral from Sell and the price target was raised to $130 from $104 at Goldman Sachs.

Lam Research Corp. (NASDAQ: LRCX) was raised to Buy from Neutral and the price target was raised to $231 from $197 at Goldman Sachs.